Scienza Health

Newport Beach, California, United States  All United States companies → Founded 2024
Clinical AI Platform Mental Health Platform Specialty-Focused AI
Seed Round (no funding total reported yet) — No funding

Products

GIA® by Scienza Health
Scienza Health
Clinical Decision Support & Reference
GIA® by Scienza Health is a multimodal AI screening platform that combines speech biomarkers with computer vision data to screen for cognitive, neurological, and behavioral conditions like Parkinson's disease and cognitive decline.

See all 1 product →

About Scienza Health

Scienza Health, formerly known as MemoryCareAI, is a healthcare AI company dedicated to transforming the detection, monitoring, and management of cognitive and behavioral health conditions, particularly within post-acute and long-term care settings. The company’s core offering is GIA®, an AI Co-Clinician powered by digitalhumanOS™, which leverages Voice AI, Computer Vision, and Speech Biomarkers. GIA® conducts comprehensive clinical screenings for 46 conditions, including Mild Cognitive Impairment (MCI), Alzheimer’s, Parkinson’s, depression, anxiety, and PTSD, through natural conversations in 92 languages.

Scienza Health’s platform is built upon a vast proprietary dataset of over 12.3 million longitudinal patient records and 27 billion clinical events, enabling real-time analysis of over 2,500 speech biomarkers. This foundation allows for clinically validated, real-time analysis to detect early signs of various conditions. Beyond screening, GIA® automates the entire patient interaction workflow, from intake conversations and appointment scheduling to follow-ups, CPT code assignment, and direct transcription into Electronic Health Records (EHRs). The platform integrates seamlessly with major EHR systems like PointClickCare, Epic, Cerner, and MatrixCare, and is available on Samsung Health Grade Galaxy devices, iOS, and web-enabled devices, including accessibility via landline.

Focus Areas

Voice AI speech biomarkers digital humans cognitive screening neurological screening behavioral health screening Alzheimer's Mild Cognitive Impairment (MCI) depression anxiety PTSD healthcare workflow automation post-acute care long-term care B2B SaaS Neurotech

Business Intelligence

PartnershipsPointClickCare, Samsung, AWS Partner Network, PACE Cardiology
AcquisitionsMemoryCareAI (rebranded to Scienza Health)
TechnologydigitalhumanOS™ (clinical intelligence operating system), GIA® (Generative Intelligence Architecture - AI Co-Clinician Digital Human®), cloud-native (AWS Partner Network), multimodal (Voice AI, Computer Vision, Speech Biomarkers), integrates with major EHR systems (PointClickCare, Epic, Cerner, MatrixCare, Netsmart, American HealthTech) via API and HL7 FHIR, bundled on Samsung Health Grade Galaxy devices
FDA ClearancesClass 2 registered (for GIA®) cleared products (estimated)

What Physicians Need to Know

Voice AI & Speech Biomarkers
Scienza Health specializes in FDA-registered Voice AI technology and speech biomarkers, analyzing over 2,500 speech biomarkers across 46 clinical conditions from a 40-second natural conversation. This includes detecting subtle acoustic features, prosody, timing, and linguistic patterns that the human ear might miss, signaling early-stage neurological, respiratory, and psychiatric conditions. They also incorporate computer vision to track 436 visual biomarker data points, such as facial micro-expressions, limb movement, gait patterns, and torso posture, to identify early indicators of conditions like tardive dyskinesia, Parkinson's, depression, and PTSD.
Digital Humans (GIAu00ae)
Their AI Co-Clinician, GIAu00ae, is a patient-facing Digital Humanu00ae that conducts full clinical screenings via video, voice, or even landline. GIAu00ae engages patients in natural conversations, making the screening feel less like a clinical test, and then delivers results, clinical notes, full transcripts, and patient videos to the EHR in real-time.
Comprehensive Screening & Early Detection
Scienza Health's digitalhumanOSu2122 platform screens for 46 cognitive, neurological, and behavioral conditions, including Alzheimer's, Mild Cognitive Impairment (MCI), depression, anxiety, and PTSD. This comprehensive approach aims to close the gap in undetected conditions, particularly in post-acute and long-term care settings where vulnerable patients often receive less support. The platform is designed to identify early risk signals before symptoms become clinically obvious, allowing for timely intervention.
Healthcare Workflow Automation
Scienza Health automates end-to-end workflows, from patient intake through follow-up, without adding burden to clinical teams. This includes automated intake, cognitive and behavioral screening, daily rounds, and post-discharge follow-up calls, which boast a 98% completion rate without added staff involvement. The system generates documentation from clinical interactions, reducing manual entry and ensuring consistent documentation.
Post-Acute & Long-Term Care Focus
The company is purpose-built for the U.S. post-acute and long-term care market, addressing the operational realities of high patient volume, limited staff bandwidth, and the need for documentation that integrates with existing systems of record. Their solutions are designed to scale effortlessly and adapt to census, payer mix, and clinical priorities.
B2B SaaS Neurotech
Scienza Health operates as a B2B SaaS Neurotech platform, leveraging AI for early detection and personalized care for cognitive decline. Their digitalhumanOSu2122 is a clinical intelligence operating system built on one of the largest proprietary clinical datasets, comprising 12.3 million longitudinal patient records and 27 billion clinical events.
Physician Tip

For physicians, Scienza Health's GIAu00ae offers a significant advantage by providing comprehensive cognitive, neurological, and behavioral health screening *before* the patient even walks into the exam room. A 40-second natural conversation with GIAu00ae can screen for 46 conditions, with structured results, clinical notes, and suggested CPT codes delivered to the EHR in under two minutes for your review. This eliminates the need for staff to administer lengthy screening tools like PHQ-9s or MoCAs, freeing up valuable clinician time to focus on patient care rather than intake paperwork. Furthermore, GIAu00ae can continuously monitor high-risk patients between appointments, flagging deterioration before the next visit and enabling proactive intervention. The platform is peer-reviewed across 19 published studies, demonstrating high accuracy for conditions like depression (AUC 0.874), anxiety (AUC 0.884), PTSD (AUC 0.907), and Parkinson's disease (AUC 0.97). Scienza Health emphasizes that their AI is a tool to *support* clinical judgment, not replace it, with every result requiring human review before becoming part of the clinical record.

Scienza Health's digitalhumanOSu2122 is designed for seamless integration with major Post-Acute Care/Long-Term Care (PAC/LTC) and health system EHRs, including PointClickCare, Epic, Cerner, MatrixCare, Netsmart, and American HealthTech, through direct API and HL7 FHIR integration. The platform is also bundled on Samsung Health Grade Galaxy devices (including Samsung DeX) and is available on iOS and any web-enabled device, with accessibility even by landline for residents without devices. This broad compatibility ensures that the technology can be deployed within existing workflows with minimal disruption.

Products by Scienza Health

1 product in the directory

GIA® by Scienza Health
Scienza Health
Clinical Decision Support & Reference
GIA® by Scienza Health is a multimodal AI screening platform that combines speech biomarkers with computer vision data to screen for cognitive, neurological, and behavioral conditions like Parkinson's disease and cognitive decline.

What the Web Says

Scienza Health, formerly MemoryCareAI, develops GIAu00ae, an AI co-clinician powered by digitalhumanOSu2122 that screens for 46 clinical conditions using voice biomarker analysis. The company focuses on post-acute and long-term care settings to detect cognitive, neurological, and behavioral health conditions. GIAu00ae integrates with existing EHR systems and aims to improve patient outcomes, maintain star ratings for facilities, and enhance financial performance.

Overall: Mixed

Strengths

  • Screens for 46 clinical conditions using voice AI and speech biomarkers.
  • Integrates with major EHR systems like PointClickCare, MatrixCare, Epic, and Cerner.
  • Offers 92-language capability for diverse patient populations.
  • Results are ready for clinician review in under 2 minutes and automatically write back to the EHR.
  • Clinically validated with 19 peer-reviewed studies.
  • Aims to improve patient outcomes, reduce hospital readmissions, and enhance survey results.

Limitations

  • No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit.
  • The technology is designed to support, not replace, clinical judgment, requiring human review of all results.
  • Limited public information on pricing or specific user experiences outside of company-provided details.

Based on reviews from: G2, Glassdoor, Capterra, Scienza Health Website, Reddit

Last updated: 2026-06-20

Videos

News, demos, and interviews about Scienza Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Scienza Health →

View all on YouTube

Press & Coverage

Business Wire / Scienza Health
Scienza Health and Samsung Expand AI Care Experience Across Galaxy Devices and TVs
Scienza Health and Samsung announced a collaboration to deliver advanced patient screening, engagement, and monitoring through Galaxy smartwatches, phones, and tablets. Scienza's digitalhumanOSu2122 and ERaaSu2122 platform uses ambient speech analysis and real-time biometric data for cognitive and neurological health screenings, automating clinical workflows. The program launched in October 2025 with rollout to skilled-nursing facilities, assisted living communities, health systems, and home care providers.
2025-10
Scienza Health
Scienza Health Emerges from Stealth with GIAu00ae, the AI Co-Clinician for Clinical Screening, at HLTH 2025
Scienza Health emerged from stealth at HLTH 2025, introducing GIAu00ae, an AI co-clinician for cognitive, behavioral, and neurological screening. GIAu00ae is designed for post-acute and long-term care, addressing the under-detection of these conditions due to staffing constraints. The platform screens for 46 clinical conditions in under five minutes.
2025-10
PR.com
MemoryCareAI Transitions to Scienza Health, Advancing Early Detection with AI and Extensive Patient Data
MemoryCareAI rebranded to Scienza Health, reflecting an expanded focus on AI-driven research in cognitive and behavioral health. The company utilizes patented, clinically validated speech biomarker technology for early detection of conditions like MCI, Alzheimer's, Parkinson's, depression, anxiety, and PTSD. Their platform is supported by over 2 million patient records.
2025-03
Scienza Health
Scienza Health's GIA Now Screens for Depression, Anxiety, and PTSD in 40 Seconds
Scienza Health announced that its GIAu00ae platform now screens for depression, anxiety, and PTSD with high accuracy from a 40-second natural conversation. This addresses the issue of millions of American employees living with mental illness who receive no treatment.
2026-04
Scienza Health
Scienza Health Reports 14,600+ Facility Reach Following PointClickCare Marketplace Launch at HIMSS 2026
Scienza Health announced that its GIAu00ae platform is now accessible to over 14,600 post-acute and long-term care facilities through the PointClickCare Marketplace. This integration enables multimodal clinical AI screening with real-time EHR write-back.
2026-03
Scienza Health
Clinical AI in Post-Acute Care: 2026 Year in Review
This review discusses the deployment of clinical AI in post-acute and long-term care, highlighting how Scienza Health's GIAu2122 supports earlier detection of conditions like depression, anxiety, and Parkinson's. The platform leverages 12.3 million longitudinal patient records and 27 billion clinical events to improve patient outcomes amidst staffing shortages.
2026-04
Scienza Health
What is an AI Co-Clinician? | First Deployed by Scienza Health (2024)
This article defines the AI co-clinician model, noting that Scienza Health deployed the first commercial AI co-clinician, GIAu00ae, in 2024. GIAu00ae screens, documents, and follows up with patients under physician authority, validated by 19 peer-reviewed studies and integrated with major EHR systems.
2026-05
Scienza Health
AI Clinical Screening in California
Scienza Health's GIAu00ae platform is designed to comply with California's strict AI regulations in healthcare, including AB 2013, AB 3030, and the CCPA. The platform screens for 46 conditions in 40 seconds with zero clinical staff, providing transparency on training data and explicit AI-generation labeling.
2026-06

Frequently Asked Questions

Scienza Health leverages advanced Voice AI and proprietary speech biomarkers to detect subtle changes in speech patterns indicative of cognitive and neurological conditions like Alzheimer's, MCI, depression, anxiety, and PTSD. Our technologies are validated through rigorous clinical studies and peer-reviewed research, demonstrating high accuracy and reliability in identifying early markers of these conditions.
Scienza Health's digital humans and AI tools are designed for seamless integration with existing EHR and healthcare management systems, automating routine tasks such as patient intake, cognitive screening, and data collection. This streamlines workflows in post-acute and long-term care, reducing administrative burden and allowing healthcare professionals to focus more on direct patient care.
Scienza Health prioritizes patient data security and privacy, adhering to stringent compliance standards such as HIPAA, GDPR, and other relevant healthcare regulations. We employ robust encryption, access controls, and regular security audits to ensure the utmost protection of sensitive patient information, including Neurotech and behavioral health data.
Scienza Health offers flexible B2B SaaS pricing models tailored to the specific needs and scale of healthcare organizations, typically based on user licenses or service utilization. We provide comprehensive support, including dedicated account management, technical assistance, and ongoing training to ensure smooth implementation and optimal use of our platforms.
Healthcare providers utilizing Scienza Health's solutions have reported significant improvements in early detection rates for cognitive and behavioral health conditions, leading to more timely interventions and better patient outcomes. Our platforms also contribute to enhanced operational efficiency by automating screening processes and reducing the time burden on clinical staff.
Scienza Health is committed to the ethical development and deployment of AI, actively working to mitigate biases in our algorithms through diverse data sets and continuous validation. We prioritize transparency and provide clear guidelines for the appropriate use of our tools, ensuring they augment rather than replace clinical judgment in sensitive areas like neurological and behavioral health screening.
Scienza Health actively seeks strategic partnerships with leading healthcare providers, research institutions, and technology companies to expand our reach and enhance our product offerings. These collaborations are integral to our long-term vision, fostering innovation, ensuring market relevance, and contributing to the sustained growth and stability of our company.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.